Veracyte
VCYT
$19.87
Share price
-1.29%
Change (1 day)
-13.00%
Change (1 year)
Categories
Veracyte (VCYT) - P/B ratio
P/B ratio as of May 2024 : 1.47
According to Veracyte's latest financial reports the company has a price-to-book ratio of 1.47.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Veracyte - P/B ratio (from 2013 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.92 | 21.52% |
| 2022-12-31 | 1.58 | -40.67% |
| 2021-12-31 | 2.67 | -60.32% |
| 2020-12-31 | 6.73 | 16.25% |
| 2019-12-31 | 5.79 | -10.23% |
| 2018-12-31 | 6.45 | 7.94% |
| 2017-12-31 | 5.97 | 64.46% |
| 2016-12-31 | 3.63 | -6.64% |
| 2015-12-31 | 3.89 | -26.04% |
| 2014-12-31 | 5.26 | -3.18% |
| 2013-12-31 | 5.43 | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | 3.51 | 137.99% | 🇺🇸 USA |
 Myriad Genetics MYGN | 2.25 | 52.61% | 🇺🇸 USA |
 Biocept
BIOC | 3.94 | 167.19% | 🇺🇸 USA |